Image_1_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

“…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”

Inc exhibits key properties of a Cul3 adaptor in neurons in vivo. by Qiuling Li (390393)

“…<p><b>(A)</b> Co-immunoprecipitation of 3×FLAG-Inc and 3×FLAG-3×HA-Cul3 from male whole animal lysates. …”

Image_4_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

“…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”

Associations between HbA1c levels and mortality and diabetes complications. by Haipeng Ma (6792266)

“…The risk increases steadily with increasing HbA1c levels, with no clear inflection point. D: RCS curves for CKD risk. …”

Image_6_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

“…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”

Image_3_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

“…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”

Procaine also promotes changes on mature osteo/odontoblasts. by Carmen Herencia (172829)

K13 shows an increased association with the mitochondria post DHA pulse. by Nina F. Gnädig (8735760)

NeuroD1 suppresses ferroptosis by upregulating GPX4. by Ping Huang (30439)

Potency of CCh (pEC₅₀) (dark blu) and atropine (pA₂) (light blu) on ileum (a) and on distal colon (red) and (pink) respectively. by Rita Aldini (92787)

“…The dotted line shows the control values for Atropine pA₂. When error bar are not shown these are covered by the point itself. …”

Cavity-Modulated Proton Transfer Reactions by Fabijan Pavošević (2181412)

“…Depending on the cavity mode polarization direction, we show that the optical cavity can increase the reaction energy barrier by 10–20% or decrease the reaction barrier by ∼5%. By using first-principles methods, this work establishes strong light-matter coupling as a viable and practical route to alter and catalyze proton transfer reactions.…”

AF related miRNA-gene regulatory networks build using Cytoscape. by Joana Larupa Santos (8822501)

“…<p>MiRNAs previously associated with AF were selected to create a subset of the regulatory networks. A. Up-regulated miRNAs and candidate gene targets down-regulated in right atrial biopsies of AF patients compared to control subjects. …”

WIN reduced bone resorption and MMP-9-activity in a capsaicin sensitive manner. by Svantje Tauber (121637)

“…Additional treatment with capsaicin (CIC) antagonized this decrease. Data are shown as means +/− SD, n = 5. (b) MMP-9-activity-ELISA of conditioned medium of osteoclasts. …”

The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review by Messia Nazar (20635096)

“…This increase was dose-dependent and was caused by a decrease in the activity of coagulation factors II, VII, IX and X. …”

Negative feedback minimizes competition between stress σ factors for RNA polymerase. by Jatin Narula (249242)

S-Nitrosoglutathione Acts as a Small Molecule Modulator of Human Fibrin Clot Architecture by Ryon M. Bateman (141170)

Mef2a^KO mice show normal behavior. by M. Waseem Akhtar (326982)

“…Right, the bar graph shows expression levels of Mef2 isoforms in the hippocampus of 4 week old animals (n=3/genotype), detected by quantitative PCR. The fold change in RNA was calculated using the comparative Ct method, normalizing to GAPDH as a control. …”

Use of quantitative proteomics identifies a putative TvROM1 substrate. by Angelica M. Riestra (838706)

“…<b>(C)</b> The predicted TM domains of the five putative substrates identified in <b>A</b>, and the percent decrease in protein levels with 3,4-DCI <i>vs</i>. …”

Supplementary Data 8 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk by Tao Sun (91038)

Perme score over the first 27 days of ICU admission. by Ricardo Kenji Nawa (10474312)